Arcadia Biosciences (RKDA) Projected to Release Earnings on Wednesday

Arcadia Biosciences (NASDAQ:RKDA) is expected to announce its Q2 2026 results before the market opens on Wednesday, August 19th. Analysts expect Arcadia Biosciences to announce earnings of ($0.56) per share and revenue of $1.90 million for the quarter. Parties can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 20, 2026 at 4:00 PM ET.

Arcadia Biosciences (NASDAQ:RKDA) last issued its earnings results on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). The company had revenue of $1.10 million during the quarter, compared to the consensus estimate of $1.60 million. Arcadia Biosciences had a negative return on equity of 113.73% and a negative net margin of 195.94%.

Arcadia Biosciences Stock Up 2.7%

RKDA opened at $0.67 on Wednesday. The stock’s fifty day moving average is $0.74 and its two-hundred day moving average is $1.23. The company has a market capitalization of $1.61 million, a P/E ratio of -0.12 and a beta of 0.56. Arcadia Biosciences has a 52 week low of $0.59 and a 52 week high of $6.71.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 25th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.